Ching L Tseng

US Patent:

20110251162, Oct 13, 2011

Filed:

Sep 25, 2009

Appl. No.:

13/120618

Inventors:

George Y. Liu - Irvine CA, US
Ching Wen Tseng - Los Angeles CA, US

Assignee:

CEDARS-SINAI MEDICAL CENTER - Los Angeles CA

International Classification:

A61K 31/56
A61K 31/196
A61K 31/18
A61P 29/00
A61K 31/53
A61K 31/444
A61K 31/40
A61K 31/407
A61K 31/616
A61K 31/381

US Classification:

514169, 514165, 514567, 514605, 514448, 514243, 514334, 514423, 514413

Abstract:

The present subject matter relates to pathogenesis of MRSA. Specifically, the present disclosures identifies the pro-inflammatory properties of PVL as the cause of MRSA. Viewed from this new perspective, the present subject matter achieves novel methods and apparatus for treating MRSA infection in a subject involving the administration of an anti-inflammatory drug to the subject. Furthermore the present subject matter teaches methods and apparatus for treating a Panton-Valetine leukocidin associated infection in a subject involving the administration of an anti-inflammatory drug to the subject.